HUAWEI
During the Huawei Day 0 Forum at MWC Barcelona 2022, Huawei released a series of new IT products and solutions as part of a new "intelligent IT foundation" for operators. David Wang, Executive Director of the Board and Chairman of the ICT Infrastructure Managing Board at Huawei, explained in his keynote speech titled "+IT, New Growth" that this reliable and efficient IT foundation will help operators go intelligent, increase revenue, reduce costs, boost efficiency, and ultimately achieve new growth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220228005736/en/
With the rapid development of emerging technologies like 5G, IoT, cloud computing, and intelligence, operators have put their own digital transformations at the top of their agendas so that they can later help other B2B industries to go digital. This kind of transformation however requires IT infrastructure upgrades, multi-cloud collaboration, and quick market wins to generate more momentum.
Wang explained that Huawei's intelligent IT foundation is specifically designed to help operators meet these new requirements. This foundation includes a fully-collaborative distributed cloud and an all-scenario data pool.
At the same event, Huawei also launched the industry's first ever distributed, cloud-native solution. This fully-collaborative cloud helps operators to achieve ICT orchestration, cloud-network synergy, and cloud-edge synergy. The architecture supports both data and media platforms as a service for operators and application platform as a service (aPaaS) for industry customers. This delivers guaranteed experiences for app users unlimited by geography, multi-cloud collaboration, and data traffic. The company currently says that one day, it hopes to offer everything as a service.
Huawei also announced a new series of data infrastructure products as part of its OneStorage strategy to support continual storage evolution. As data types continue to diversify, applications have become more affordable and data protection is more important than ever. Huawei's OneStorage solution gives operators the efficiency they need to meet these requirements through on-demand resource provisioning, intelligent data management, and multi-cloud convergence. It is currently Huawei's best offering for operators who want to keep their data infrastructure up-to-date and explore new businesses.
By the end of 2021, HUAWEI CLOUD and its partners had built 61 availability zones in 27 areas to serve more than 170 countries and regions. It has also started working with more than 120 operators in the cloud service market to help enterprise customers go digital. It currently offers more than 50 scenario-specific cloud services for nine vertical markets, such as manufacturing, retail, and healthcare, to go digital. These intelligent and efficient data storage services offerings are currently used by 300 operators worldwide and the OceanStor Dorado solution has been named a Leader in Gartner's Magic Quadrant for six years in a row.
Reliable, efficient, and intelligent IT infrastructure is critical for operators to go digital. Huawei wants to continue working with operators to roll out IT infrastructure, help industry go digital, and achieve new growth together.
MWC22 Barcelona will run from February 28 to March 3 in Barcelona, Spain. Huawei will showcase its products and solutions at stand 1H50 in Fira Gran Via Hall 1. Together with global operators, industry professionals, and opinion leaders, we will dive into topics such as industry trends, GUIDE to the Future, and green development to envision the future of digital networks. For more information, please visit: https://carrier.huawei.com/en/events/mwc2022 .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005736/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
